Linkedin
Sign in
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Type here...
Search
Home
About
Editor’s Corner
Contribute
Contact Us
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
Solutions & Pricing
Partner
Instagram
Linkedin
Twitter
Subscribe
Subscribe
Thursday, April 23, 2026
23.2
C
Bengaluru
Home
About
Editor’s Corner
Contribute
Contact Us
My account
Get into your account.
Login
Register
type here...
Search
Facebook
Linkedin
Twitter
Youtube
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
Indian Pharma in September 2025: Momentum, Disruption & Caution
0
Indian Pharma in September 2025: Momentum, Disruption & Caution By...
Key Highlights: Major Indian Pharma Companies – July 2025
0
Aurobindo Pharma Limited Began sales to Europe through its China-based...
Indian #Pharma Market (IPM) – August 2020 Sales
0
The COVID crisis has impacted IPM negatively - the...
Career – What Makes Us Tick?
0
Who we are, What we think and How we do
Why Most AI Healthcare Tools Stall at the Pilot Stage
0
Artificial intelligence (AI) in healthcare consistently demonstrates remarkable technical...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Marketing
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Policies/Sales
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Strategy
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Subscribe
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
Blinkit, Zepto, Instamart: Who Will Own India’s At‑Home Diagnostics Market?
0
India’s diagnostics market is undergoing a quiet but profound...
A Social Experiment
0
Articles by K. Hariram, Vivek Hattangadi, Hanno Wolfram, RB Balakrishna and Rajiv Jayaraman
Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift
0
In big pharma, leadership changes are rarely impulsive. They...
Crafting a Digital Strategy
0
A Digital-in-pharma special issue. Announcement for ACG-MedicinMan's "Pharmaceutical Marketing in the New Age" conference to be held in March 2018
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Marketing
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Policies/Sales
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Strategy
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Subscribe
Transfer-Snapshot